Skip to Content

Label Changes for:

Detrol (tolterodine tartrate tablets)

September 2008

Changes have been made to the PRECAUTIONS and PATIENT PACKAGE INSERT sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- September 2008


The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format.

Summary View


Sections Modified


  • General
    • Decreased Gastrointestinal Motility
    • Myasthenia Gravis


  • What should I tell my doctor before starting Detrol?
    • Before starting Detrol, tell your doctor about all of your medical conditions, including if you:
    • have a condition called myasthenia gravis